首页> 外国专利> METHOD FOR PREVENTING THE DEVELOPMENT OF NONTHROMBOGENIC COMPLICATIONS IN POSTOPERATIONAL PERIOD

METHOD FOR PREVENTING THE DEVELOPMENT OF NONTHROMBOGENIC COMPLICATIONS IN POSTOPERATIONAL PERIOD

机译:预防术后非血栓性并发症发展的方法

摘要

FIELD: medicine, surgery.;SUBSTANCE: one should study functional state of hemostasis system based upon electro- and biochemical coagulogram, and at availability of a friable clot: the value of minimal amplitude of electrocoagulogram being above 0.6 c.u. - it is necessary to introduce dicynon per 250 mg intravenously 4 times daily and additionally in case of hypothrombinemia one should carry out infusion of freshly frozen plasma intravenously at the dosage of 3-6 ml/kg patient's body weight, and at availability of hyperactivation of fibrinolysis one should introduce inhibitors of proteases: at first intravenously by bolus technique, and then - as intravenous continuous infusion; moreover, in case of medicinal correction of hemostasis system with anticoagulants in case of hypothrombinemia their dosages should be decreased till achieving normocoagulation. The present innovation enables to restore body hemostasis system due to individually matched therapeutic tactics that, in its turn, enables to prevent postoperational complications.;EFFECT: higher efficiency and accuracy of prophylaxis.;1 cl, 1 dwg, 3 ex, 1 tbl
机译:领域:医学,外科手术;研究对象:应该基于电凝和生化凝结图,以及在易碎凝块的情况下研究止血系统的功能状态:电凝图的最小振幅值应大于0.6c.u。 -有必要每天每250毫克静脉注射地西农4次,每次4次;如果发生低血栓症,则应以3-6毫升/千克患者体重的剂量静脉内注入新鲜冰冻血浆,并应给予高剂量的纤维蛋白溶解者应引入蛋白酶抑制剂:首先通过推注技术静脉内注射,然后-作为静脉内连续输注;此外,在血凝蛋白不足的情况下,如果使用抗凝剂对止血系统进行药物矫正,则应降低剂量直至达到正常凝结。本发明能够通过单独匹配的治疗策略来恢复人体止血系统,从而可以预防术后并发症。;效果:预防的效率和准确性更高; 1 cl,1 dwg,3 ex,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号